John Pang1, Wojciech K Mydlarz1, Zhen Gooi1, Kevin M Waters2, Justin Bishop2, James J Sciubba3, Young J Kim1, Carole Fakhry1,3. 1. Department of Otolaryngology and Head and Neck Surgery, Johns Hopkins University School of Medicine, The Johns Hopkins Hospital, Baltimore, Maryland. 2. Department of Pathology, Johns Hopkins University School of Medicine, The Johns Hopkins Hospital, Baltimore, Maryland. 3. Milton J. Dance Jr. Head and Neck Cancer Center, Johns Hopkins Head and Neck Surgery, Baltimore, Maryland.
Abstract
BACKGROUND: Follicular dendritic cell sarcoma (FDCS) is a rare lymphoid neoplasm presenting in the head and neck. There are no pooled analyses of head and neck FDCS cases in the English language literature. METHODS: A MEDLINE and PubMed review of cases from 1978 to February 2014 was performed. Demographics, clinicopathologic data, and outcomes were summarized. RESULTS: We presented 2 patients and analyzed 97 cases. The mean age was 42.7 years (SD = 16.3 years). Outcomes were available for 76 patients. Tumors ≤4 cm had better disease-free survival (63% vs 28% at 5 years; p = .0282). Locoregional recurrence was significantly less likely with surgery and radiation compared to surgery alone (15% vs 45%; p = .019) and in patients receiving a neck dissection (10% vs 43%; p = .046). CONCLUSION: This pooled analysis provides the largest sample size of FDCS of the head and neck to date and suggests that radiation and neck dissection may be beneficial to locoregional oncologic control.
BACKGROUND:Follicular dendritic cell sarcoma (FDCS) is a rare lymphoid neoplasm presenting in the head and neck. There are no pooled analyses of head and neck FDCS cases in the English language literature. METHODS: A MEDLINE and PubMed review of cases from 1978 to February 2014 was performed. Demographics, clinicopathologic data, and outcomes were summarized. RESULTS: We presented 2 patients and analyzed 97 cases. The mean age was 42.7 years (SD = 16.3 years). Outcomes were available for 76 patients. Tumors ≤4 cm had better disease-free survival (63% vs 28% at 5 years; p = .0282). Locoregional recurrence was significantly less likely with surgery and radiation compared to surgery alone (15% vs 45%; p = .019) and in patients receiving a neck dissection (10% vs 43%; p = .046). CONCLUSION: This pooled analysis provides the largest sample size of FDCS of the head and neck to date and suggests that radiation and neck dissection may be beneficial to locoregional oncologic control.
Authors: Jinru Shia; Wen Chen; Laura H Tang; Diane L Carlson; Jin Qin; Jose G Guillem; Jennifer Nobrega; W Douglas Wong; David S Klimstra Journal: Virchows Arch Date: 2006-06-07 Impact factor: 4.064
Authors: Philippe Clement; Patrick Saint-Blancard; François Minvielle; Pierre Le Page; Michel Kossowski Journal: Am J Otolaryngol Date: 2006 May-Jun Impact factor: 1.808
Authors: Mónica B Romero-Guadarrama; Olinka Reyes-Posada; María M Hernández-González; Marco A Durán-Padilla Journal: Ann Diagn Pathol Date: 2008-07-26 Impact factor: 2.090
Authors: R Fonseca; M Yamakawa; S Nakamura; P van Heerde; M Miettinen; T W Shek; O Myhre Jensen; M C Rousselet; A Tefferi Journal: Am J Hematol Date: 1998-10 Impact factor: 10.047
Authors: Richard L Schilsky; Dina L Michels; Amy H Kearbey; Peter Paul Yu; Clifford A Hudis Journal: J Clin Oncol Date: 2014-06-09 Impact factor: 44.544
Authors: Erica F Andersen; Christian N Paxton; Dennis P O'Malley; Abner Louissaint; Jason L Hornick; Gabriel K Griffin; Yuri Fedoriw; Young S Kim; Lawrence M Weiss; Sherrie L Perkins; Sarah T South Journal: Mod Pathol Date: 2017-06-16 Impact factor: 7.842